Covid-19: New coronavirus variant is identified in UK

  title={Covid-19: New coronavirus variant is identified in UK},
  author={Jacqui Wise},
  • J. Wise
  • Published 16 December 2020
  • Medicine
  • BMJ
England’s health secretary, Matt Hancock, has told parliament that a new variant of covid-19 has been identified and may be driving infections in the south east, leading to headlines about “mutant covid.” Jacqui Wise answers some common questions 

COVID-19: A Systematic Review of the Transmissibility, Pathogenesis, Entry Factors, and Signature Immune Response

A systematic review of the literature was performed in accordance with PRISMA guidelines to gain insight into the transmissibility, pathogenesis, entry factors, and immune response of COVID-19, and the latest knowledge about SARS-CoV2 is summarized.

A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development

This review brings a spotlight on the mode of transmission, pathophysiology, genetic structure, mutants of SARS-CoV-2, progress on the vaccination and some recent peculiar disguisable facts about the novel coronavirus 2019.

Emergence of SARS‐CoV‐2 Variant: A wake‐up call for Pakistan's overburdened healthcare system

The current pandemic has uncovered significant challenges and flaws in Pakistan's emergency and health processes concerning infectious disease prevention, and efficient government interventions and concrete actions must be taken to educate peoples and deal with their wrong perceptions.

A review on how exactly covid-19 vaccination works

This review aims to highlight and summarize the ongoing process and development in making Covid Vaccine, a novel vaccine for novel coronavirus.

The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?

The detection of the new mutant strains of SARS-CoV-2 in many countries prompted border closures, lockdowns, and new restrictions and ultimately massive economic loss and further deaths.

Prevalence of COVID-19 and Possible Antigenic Drifts in SARS-CoV-2 Spike Protein in Kurdistan Region-Iraq

The results revealed that the prevalence of COVID-19 is 1.9% in the region and is still in parallel to the neighbouring countries and the entire world and the detection of N501Y and A570D mutations indicate the circulation of the UK variant of concern in Kurdistan region.

SARS-CoV-2 variants: A double-edged sword?

This review has highlighted major SARS-CoV-2 variants as well as other local strains along with their specific mutations, suspected changes in their characteristics, and their impact on the current pandemic and vaccine efficacy.

The race for a COVID-19 vaccine: where are we up to?

A general understanding of the fast-tracked clinical trial procedures is provided and recent successes in preclinical and clinical trials are highlighted to generate a clearer picture of the progress of COVID-19 vaccine development.

The 501.V2 and B.1.1.7 variants of coronavirus disease 2019 (COVID-19): A new time-bomb in the making?

  • T. Arif
  • Biology
    Infection Control & Hospital Epidemiology
  • 2021
The second wave of coronavirus disease 2019 (COVID-19) has been incessantly causing catastrophe across the world; the need for immediate action to cushion the pandemic’s health and economic repercussions, protect susceptible populations, and set the stage for a lasting recovery is highlighted.